Skip to main content
Premium Trial:

Request an Annual Quote

"We Think That's Poppycock"

Linda Avey from 23andMe appeared on CNBC's Healthy Horizons to discuss her company. The host asks Avey what she would say to critics who say the diseases arise from complex interactions of genes and environment and that what 23andMe provides is a small amount of information that could be misinterpreted. Avey replies: "We think that's poppycock. We think we should really be able to engage people directly."

H/T: The Genetic Genealogist

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.